British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Kennedy, Nicholas A Jones, Gareth-Rhys Lamb, Christopher A Appleby, Richard Arnott, Ian Beattie, R Mark Bloom, Stuart Brooks, Alenka J Cooney, Rachel Dart, Robin J
Kennedy, Nicholas A
Jones, Gareth-Rhys
Lamb, Christopher A
Appleby, Richard
Arnott, Ian
Beattie, R Mark
Bloom, Stuart
Brooks, Alenka J
Cooney, Rachel
Dart, Robin J
Citations
Altmetric:
Affiliation
Royal Devon and Exeter NHS Foundation Trust; University of Exeter; University of Edinburgh; Western General Hospital; Newcastle University; Newcastle upon Tyne Hospitals NHS Foundation Trust; Chelsea and Westminster Hospital NHS Foundation Trust; University Hospital Southampton NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; Sheffield Teaching Hospitals NHS Foundation Trust; University Hospital Birmingham NHS Foundation Trust; University of Birmingham; King's College London; The Royal Free Hospital; Torbay and South Devon NHS Foundation Trust; University Hospitals Bristol NHS Foundation Trust; Glasgow Royal Infirmary; University of Glasgow; Royal Hospital for Children; St Mark's Hospital; Imperial College London; University Hospital of Wales; King's College Hospital NHS Foundation Trust; The Pennine Acute Hospitals NHS Trust; University of Manchester; Barts and the London School of Medicine and Dentistry; Barts Health NHS Trust; Cambridge University Hospitals NHS Foundation Trust; St George's University Hospitals NHS Foundation Trust; University of London; Imperial College Healthcare NHS Trust; Liverpool University Hospitals NHS Foundation Trust; University of Liverpool; Hull University Teaching Hospitals NHS Trust; Leeds Teaching Hospitals NHS Trust; Salford Royal NHS Foundation Trust; Crohn's and Colitis UK; Guy's and St Thomas' NHS Foundation Trust
Other Contributors
Publication date
2020-04-17
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.
Citation
Kennedy NA, Jones GR, Lamb CA, Appleby R, Arnott I, Beattie RM, Bloom S, Brooks AJ, Cooney R, Dart RJ, Edwards C, Fraser A, Gaya DR, Ghosh S, Greveson K, Hansen R, Hart A, Hawthorne AB, Hayee B, Limdi JK, Murray CD, Parkes GC, Parkes M, Patel K, Pollok RC, Powell N, Probert CS, Raine T, Sebastian S, Selinger C, Smith PJ, Stansfield C, Younge L, Lindsay JO, Irving PM, Lees CW. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2020 Jun;69(6):984-990. doi: 10.1136/gutjnl-2020-321244. Epub 2020 Apr 17.
Type
Article